BRAIDO, FULVIO
 Distribuzione geografica
Continente #
EU - Europa 22.013
AS - Asia 807
SA - Sud America 124
NA - Nord America 93
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 1
Totale 23.061
Nazione #
IT - Italia 21.990
SG - Singapore 401
CN - Cina 168
VN - Vietnam 156
BR - Brasile 79
US - Stati Uniti d'America 62
HK - Hong Kong 27
AR - Argentina 22
MX - Messico 20
ID - Indonesia 18
IQ - Iraq 10
CO - Colombia 6
FR - Francia 5
PY - Paraguay 5
AT - Austria 4
BD - Bangladesh 4
EC - Ecuador 4
MA - Marocco 4
CL - Cile 3
IN - India 3
KE - Kenya 3
NL - Olanda 3
RU - Federazione Russa 3
VE - Venezuela 3
ZA - Sudafrica 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
FI - Finlandia 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
NP - Nepal 2
PA - Panama 2
TR - Turchia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CA - Canada 1
CD - Congo 1
CR - Costa Rica 1
DE - Germania 1
GA - Gabon 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
NA - Namibia 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SE - Svezia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UG - Uganda 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 23.061
Città #
Genova 13.147
Genoa 5.458
Rapallo 1.871
Vado Ligure 1.422
Singapore 218
Bordighera 63
Ho Chi Minh City 53
Beijing 45
Hanoi 36
Ashburn 34
Hong Kong 27
Mexico City 16
Tianjin 15
Da Nang 9
Biên Hòa 8
Haiphong 7
Jakarta 6
San Jose 6
Baghdad 5
Belo Horizonte 4
São Paulo 4
Can Tho 3
Milan 3
Nairobi 3
Ninh Bình 3
Asunción 2
Bologna 2
Cao Lanh 2
Chicago 2
Ciudad del Este 2
Curitiba 2
Feira de Santana 2
Fes 2
Florianópolis 2
Guangzhou 2
Guarulhos 2
Guayaquil 2
Hải Dương 2
Jundiaí 2
Lainate 2
Lastra a Signa 2
Leesburg 2
Lấp Vò 2
Najaf 2
New York 2
Ourinhos 2
Panama City 2
Port of Spain 2
Quilmes 2
Ribeirão Preto 2
Richmond 2
Rondonópolis 2
San Gregorio di Catania 2
Santo André 2
Shanghai 2
Thái Bình 2
Uberlândia 2
Verona 2
Vĩnh Tường 2
Afikim 1
Aktobe 1
Alexandria 1
Allen 1
Alto Alegre do Pindaré 1
Anajatuba 1
Anicuns 1
Ankara 1
Aracaju 1
Atlanta 1
Bab Ezzouar 1
Baie-D'Urfé 1
Baku 1
Bandung 1
Bangkok 1
Barra do Piraí 1
Bauru 1
Belgrade 1
Belém 1
Berazategui 1
Betim 1
Bishkek 1
Boa Vista 1
Bobo-Dioulasso 1
Boca Toma 1
Bom Jardim 1
Bouïra 1
Bucaramanga 1
Buenos Aires 1
Buon Ma Thuot 1
Bình Dương 1
Bắc Giang 1
Bắc Ninh 1
Caloocan City 1
Camaragibe 1
Camaçari 1
Campinas 1
Cape Town 1
Caracas 1
Carapicuíba 1
Carpina 1
Totale 22.575
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 281
RAPP-children: A new tool for assessing quality of life in patients with asthma and rhinitis 256
null 200
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 194
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 190
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 181
Exploring the Relationship between Disease Awareness and Outcomes in Patients with Chronic Obstructive Pulmonary Disease 177
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. 175
Antiallergic drugs and quality of life. 167
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 165
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 162
Allergic diseases and their impact on quality of life. 161
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study 160
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 159
An update on allergen immunotherapy and asthma 158
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 158
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). 157
Genuair® Usability Test: Results of a National Public Survey of the Elderly 157
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases 156
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 156
Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. 155
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 155
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence 154
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 153
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 153
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 152
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. 150
RhinAsthma patient perspective: A Rasch validation study 148
Biosimilars in allergic diseases 148
The relationship between allergen immunotherapy and omalizumab for treating asthma 147
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 147
Umeclidinium for the treatment of uncontrolled asthma 146
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. 145
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. 145
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation) 145
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 145
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America 144
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context 143
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 143
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment 142
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study 141
Adherence to treatment: assessment of an unmet need in asthma. 140
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 139
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 139
Adherence to asthma treatments: 'We know, we intend, we advocate' 139
Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? 137
Pidotimod: The state of art 136
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 136
Coping with asthma: is the physician able to identify patient's behaviour? 135
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 135
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 134
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL) 134
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome 134
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. 134
Why do doctors and patients not follow guidelines? 133
Patient-reported outcomes in asthma clinical trials 133
Disease awareness in patients with COPD: measurement and extent 133
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 132
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy 132
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study 132
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 132
Quality-of-life issues in survivors to anaphylactic reactions to drugs 131
New therapies for allergic rhinitis 131
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. 131
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. 131
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. 131
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. 130
Long-acting bronchodilators improve health related quality of life in patients with COPD. 130
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 129
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 129
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 129
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 129
Does asthma control correlate with quality of life related to upper and lower airways? A real life study. 128
Continuing Medical Education:an international reality 128
Asthma treatment: 'magic bullets which seek their own targets'. 128
From "blockbusters" to "biosimilars": An opportunity for patients, medical specialists and health care providers 126
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study 126
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. 124
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 124
Phenotypes/endotypes-driven treatment in asthma 124
Worldwide differences on the concept of control of asthma. 123
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. 123
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. 123
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 123
Sleep disturbances in allergic diseases. 122
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 122
Does a low-density gas mixture or oxygen supplementation improve exercise training in COPD? 122
Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. 121
Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria 121
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 120
The anti-inflammatory properties of tiotropium 120
Allergic rhinitis in asthma. 120
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. 118
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 118
The link between allergic rhinitis and asthma: the united airways disease. 117
Aqua©: Allergy questionnaire for athletes. Development and validation 117
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. 117
Chronic obstructive pulmonary disease patient well-being and its relationship with clinical and patient-reported outcomes: a real-life observational study. 117
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement 117
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. 116
Totale 14.206
Categoria #
all - tutte 80.687
article - articoli 79.935
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 752
Totale 161.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.065 0 0 0 0 0 127 127 174 124 200 150 163
2021/20222.437 127 164 117 243 52 250 119 570 182 213 106 294
2022/20232.276 249 118 21 236 326 413 52 181 395 55 184 46
2023/20241.097 61 161 24 115 98 167 90 79 57 28 96 121
2024/20253.448 45 264 131 223 486 375 328 486 184 213 343 370
2025/20263.202 735 195 838 441 828 165 0 0 0 0 0 0
Totale 23.761